These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27988515)

  • 21. Cognitive Changes in Chronic Kidney Disease and After Transplantation.
    Van Sandwijk MS; Ten Berge IJ; Majoie CB; Caan MW; De Sonneville LM; Van Gool WA; Bemelman FJ
    Transplantation; 2016 Apr; 100(4):734-42. PubMed ID: 26479287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Vitamin D in Cognitive Function in Chronic Kidney Disease.
    Cheng Z; Lin J; Qian Q
    Nutrients; 2016 May; 8(5):. PubMed ID: 27187460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The assessment of cognitive impairment in maintenance hemodialysis patients and the relationship between cognitive impairment and depressive symptoms.
    Feng J; Lu X; Wang S; Li H
    Semin Dial; 2022 Nov; 35(6):504-510. PubMed ID: 34726291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.
    Pasi M; Salvadori E; Poggesi A; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Diciotti S; Mascalchi M; Inzitari D; Pantoni L;
    Stroke; 2015 Jan; 46(1):262-4. PubMed ID: 25395414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of cognitive dysfunction in kidney disease.
    Nasser Mel T; Shawki S; El Shahawy Y; Sany D
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1208-14. PubMed ID: 23168850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.
    Tsuruya K; Yoshida H; Haruyama N; Fujisaki K; Hirakata H; Kitazono T
    PLoS One; 2015; 10(12):e0143706. PubMed ID: 26632813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress and other risk factors for white matter lesions in chronic hemodialysis patients.
    Muñoz-Cortés M; Cabré C; Villa D; Vives JP; Arruche M; Soler J; Compte MT; Aguilera J; Jariod M; Romeu M; Giralt M; Martinez-Vea A
    Clin Nephrol; 2013 Sep; 80(3):187-97. PubMed ID: 23743154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connectivity network measures predict volumetric atrophy in mild cognitive impairment.
    Nir TM; Jahanshad N; Toga AW; Bernstein MA; Jack CR; Weiner MW; Thompson PM;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1(0 1):S113-20. PubMed ID: 25444606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression and Cognitive Impairment in Peritoneal Dialysis: A Multicenter Cross-sectional Study.
    Dong J; Pi HC; Xiong ZY; Liao JL; Hao L; Liu GL; Ren YP; Wang Q; Duan LP; Zheng ZX
    Am J Kidney Dis; 2016 Jan; 67(1):111-8. PubMed ID: 26255306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation.
    Dixon BS; VanBuren JM; Rodrigue JR; Lockridge RS; Lindsay R; Chan C; Rocco MV; Oleson JJ; Beglinger L; Duff K; Paulsen JS; Stokes JB;
    BMC Nephrol; 2016 Jan; 17():12. PubMed ID: 26801094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.
    Li W; Zhang S
    Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cross-sectional study exploring cognitive impairment in kidney failure.
    Nicholas P; Green T; Purtell L; Bonner A
    J Ren Care; 2022 Jun; 48(2):93-101. PubMed ID: 34227741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of neurovascular decoupling and cognitive impairment in patients with end-stage renal disease during a hemodialysis session: Evidence from a comprehensive fMRI analysis.
    Li P; Ma S; Ma X; Ding D; Zhu X; Zhang H; Liu J; Mu J; Zhang M
    Hum Brain Mapp; 2023 Feb; 44(3):989-1001. PubMed ID: 36269166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive performance is associated with left ventricular function in older chronic hemodialysis patients: result of a pilot study.
    Bossola M; Laudisio A; Antocicco M; Tazza L; Colloca G; Tosato M; Zuccalà G
    Aging Clin Exp Res; 2014 Aug; 26(4):445-51. PubMed ID: 24353108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive Impairment in End Stage Renal Disease Patients Undergoing Hemodialysis: Markers and Risk Factors.
    Olczyk P; Kusztal M; Gołębiowski T; Letachowicz K; Krajewska M
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.
    Xiong L; Davidsdottir S; Reijmer YD; Shoamanesh A; Roongpiboonsopit D; Thanprasertsuk S; Martinez-Ramirez S; Charidimou A; Ayres AM; Fotiadis P; Gurol E; Blacker DL; Greenberg SM; Viswanathan A
    J Alzheimers Dis; 2016 Mar; 52(1):171-8. PubMed ID: 27060947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.
    Kandiah N; Zainal NH; Narasimhalu K; Chander RJ; Ng A; Mak E; Au WL; Sitoh YY; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1203-8. PubMed ID: 25258331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease.
    Mak E; Su L; Williams GB; O'Brien JT
    Parkinsonism Relat Disord; 2015 Aug; 21(8):862-70. PubMed ID: 26004683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.